Institutional investors purchased a net $1.4 million shares of VICL during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 31.44% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Bought 1.2 Million shares of Vical Inc
ARIEL INVESTMENTS LLC Bought 196.8 Thousand shares of Vical Inc
RENAISSANCE TECHNOLOGIES LLC Bought 99.5 Thousand shares of Vical Inc